It contains the active ingredient semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA)
OKeeffe, M., et al., Knowledge gaps and weight stigma shape attitudes toward obesity
Testing was conducted by Swift Laboratory, an ISO 17025:2017-accredited third-party testing facility MIAMI, June 29, 2026 /PRNewswire-PRWeb/ -- Cata-Kor, a U.S.-based nutraceutical company focused on science-informed longevity formulations, released results from independent laboratory testing of 12 top-selling glutathione supplements purchased from Amazon.com in AprilJune 2026
Clinical management of septic arthritis in cattle
Versus Earlier GLP-1 Medications Retatrutide's 28.7% weight loss at 68 weeks substantially exceeds semaglutide's 14.9% and tirzepatide's 20.2% at similar durations
Two-hour postprandial glucose decreased by 61.3 mg/dL using the combination drug versus 10.8 mg/dL with placebo